- BEAM +2.14%
Beam Therapeutics Inc. (NASDAQ:BEAM) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Yahoo Finance · 1 week ago
Open | 23.75 |
High | 24.30 |
Low | 23.24 |
Mkt Cap | 2B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 23.79 |
52 Wk. Low | 16.95 |
52 Wk. High | 49.50 |
Related stocks
American healthcare company
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 7.41M | 69.40% ▼ |
Net Income | -98.67M | - |
Diluted EPS | -1.21 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$1.14 | - |
Q1 2024 | -$1.42 | -$1.21 |
Q4 2023 | -$1.01 | $1.73 |
S&P 500^GSPC | 5,298.37+1.27 (+0.02%) |
Dow 30^DJI | 39,906.83+37.45 (+0.09%) |
Nasdaq^IXIC | 16,701.27+2.95 (+0.02%) |
Reddit, Inc.RDDT | 63.74+13.05% |
0.4120+71.73% | |
3.5650+116.06% |